Skip to main content
DNA Labs India

RXYLT1 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A10 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

RXYLT1 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A10 NGS Genetic Test

Short Name: RXYLT1 MDDGA10 NGS Test

Also known as: Muscular Dystrophy-Dystroglycanopathy Type A10, MDDGA10, RXYLT1 Congenital Muscular Dystrophy

RXYLT1 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A10 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks from receipt of sample.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of this test is to detect pathogenic variants in the RXYLT1 gene that cause muscular dystrophy-dystroglycanopathy type A10, confirming the clinical diagnosis and enabling genetic counseling and prenatal evaluation.

Test Code
4356
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks from receipt of sample.
Fasting Required
No
Method
Next-Generation Sequencing
Step 1

Sample Collection

No fasting is required. A clinician's referral and clinical history are recommended. Genetic counseling before testing is advised to discuss the implications.

Method: Peripheral blood draw or FTA card spot

Step 2

Laboratory Analysis

Peripheral blood sample will be collected in an EDTA vacutainer by a trained phlebotomist. FTA card spot can be collected by a simple finger prick.

Step 3

Report Delivery

The sample should be labeled and transported to the laboratory as per provided instructions. No specific precautions required.

Timeline: 3 to 4 weeks from receipt of sample.

Patient Instructions

1
Before the Test:Review the clinical history and discuss with a geneticist. Sign informed consent.
2
During the Test:A single blood sample is taken. No sedation or special monitoring is required.
3
After the Test:You may resume normal activities immediately. The laboratory will contact you when the results are ready.

About This Test

Who Should Get This Test

The primary purpose of this test is to detect pathogenic variants in the RXYLT1 gene that cause muscular dystrophy-dystroglycanopathy type A10, confirming the clinical diagnosis and enabling genetic counseling and prenatal evaluation.

How to Prepare

  • No special preparation such as fasting is needed.
  • Complete a genetic counseling session to draw a pedigree chart as necessary.
  • Bring a doctor's prescription/referral if available.
  • Informed consent for genetic testing should be signed.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic counseling before and after testing is essential to understand inheritance, recurrence risks, and available management options for families affected by this rare condition."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
ContainerEDTA vacutainer / FTA card
Collection MethodPeripheral blood draw or FTA card spot

Sample Stability

Blood in EDTA: stable for 24-48 hours at 2-8°C.
Extracted DNA: stable for 6 months at -20°C.
FTA card: stable for several months at room temperature.
Sample Rejection Criteria:
  • Improperly labeled specimen
  • Clotted blood in EDTA tube
  • Hemolyzed sample
  • Sample received after prolonged transit without cold chain
  • Insufficient quantity

Understanding Your Results

The RXYLT1 gene sequence is analysed by NGS and variants are interpreted using ACMG guidelines. The result report describes whether disease-causing variants were identified, or if a variant of uncertain significance was found. It is recommended to review the report with a genetic counselor or referring clinician.
Positive (Pathogenic variant identified): Confirms the diagnosis of MDDGA10 and allows family testing.
Negative (No pathogenic variant detected): Does not rule out the condition; other genetic causes may be explored.
Variant of Uncertain Significance (VUS): Additional segregation studies or functional studies may be recommended.
⚠️ When to Consult a Doctor:

Consult a neurologist or medical geneticist if there are signs of congenital muscle weakness, developmental delay, seizures, or eye anomalies, or if there is a family history of muscular dystrophy-dystroglycanopathy.

Limitations

  • This test covers coding exons and splice junctions of the RXYLT1 gene.
  • It may not detect large gene deletions, duplications, or complex rearrangements.
  • Variants in regulatory regions or deep intronic regions will not be identified.
  • A negative result does not entirely exclude the condition if clinical suspicion remains high.

Risks & Considerations

  • Minimal risk of bruising or hematoma at the blood draw site
  • Possible dizziness or vasovagal reaction during blood collection

Interfering Factors

  • Presence of maternal cell contamination in fetal or cord blood samples
  • Low-quality DNA (degraded or insufficient quantity)
  • Very deep intronic variants or large structural rearrangements not detected by this targeted NGS approach
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.